Je et al. (2013) found that SRSF2 expression reduced (up to 7-fold) in gastric tumors [54], while Yong et al. (2016) reported that both RBM4 protein and mRNA expression levels were significantly lower in GC tissues than in the adjacent non-cancerous tissues [55]. This evidence concerns the gene RBM4 and gastric cancer.